Regenxbio's RGX-121 Lands Regenerative Medicine Advanced Therapy Designation

By Chris Wack


Regenxbio said Tuesday that the U.S. Food and Drug Administration has granted a regenerative medicine advanced therapy designation for RGX-121, an investigational one-time AAV... | May 23, 2023

Related Keywords

Chris Wack ,Drug Administration ,Dow Jones ,Regenxbio Inc Stock Exchange ,News ,Information ,Press Release ,Y ,Chris ,Back ,Regenxbio ,Aid ,Tuesday ,Hat ,The ,Wood ,End ,Drug ,Administration ,Gas ,Granted ,Regenerative ,Medicine ,Dvanced ,Therapy ,Resignation ,Or ,N ,Nvestigational Rgnx Us75901b1070 ,